The UK MHRA has validated Bavarian Nordics’ marketing authorisation application for its single-dose chikungunya vaccine.

If granted, IXCHIQ ® will become the first vaccine against the chikungunya virus (CHIKV) available in the EU for adolescents 12 years of age and older The European Commission (EC) will now review ...

Rabies is a deadly disease that damages the brain and nerves, causing symptoms such as drooling, fever, aggression and weakness. It not only impacts dogs and cats, but it can affect all mammals, i ...

Pinal County officials issued a rabies advisory after a gray fox tested positive in western Maricopa. Officials urged residents to avoid wild animals in this area, especially if they are behaving ...

Valneva Trading Down 5.9 % Valneva stock opened at $7.44 on Friday. The stock has a market cap of $604.57 million, a PE ratio of -57.23 and a beta of 1.98. Valneva has a 52 week low of $3.62 and a ...

Valneva stock opened at $7.44 on Wednesday. The business has a fifty day moving average of $5.25 and a two-hundred day moving average of $5.68. The company has a quick ratio of 2.25, a current ...

COLUMBIA, S.C. (WCSC) - The South Carolina Department of Public Health has confirmed a person was exposed to rabies by a fox found in the Lake City area. The victim, whom authorities did not identify, ...

In a report released on February 18, Justine Telliez from Kepler Capital maintained a Buy rating on Valneva (0OB3 – Research Report), with a price target of €8.10. The company’s shares ...

Ratings for Valneva (NASDAQ:VALN) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The table below summarizes their recent ratings ...

H.C. Wainwright lowered the firm’s price target on Valneva (VALN) to $17 from $18 and keeps a Buy rating on the shares following the Q4 report. The firm cites reduced sales estimates for Ixchiq ...